Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Inclusion Criteria: * Eligible for treatment with everolimus as per the locally approved label. * Presence of at least one AML ≥ 3 cm in its longest diameter using CT or MRI. Exclusion Criteria: * AML related bleeding or embolization during the 6 months prior to enrollment. * History of myocardial infarction, angina or stroke related to atherosclerosis. * Impaired lung function. * Significant hematological or hepatic abnormality. * Any severe and/or uncontrolled medical conditions.